Two cases of reversible bilateral painful gynecomastia induced by 1mg oral finasteride(Propecia®)
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, B.J. | - |
dc.contributor.author | Kim, Y.J. | - |
dc.contributor.author | Ro, B.I. | - |
dc.date.accessioned | 2022-04-11T09:40:13Z | - |
dc.date.available | 2022-04-11T09:40:13Z | - |
dc.date.issued | 2003-02 | - |
dc.identifier.issn | 0494-4739 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/56173 | - |
dc.description.abstract | Oral finasteride(Propecia®), 1mg/day, has been widely used as an effective treatment for male androgenetic alopecia since it had been approved by the Food and Drug Administration (FDA) of U.S. in December 1997. Gynecomastia has been one of the most common adverse effects in the patients who were taking 5mg of oral finasteride(Proscar®). Recently, several cases of unilateral or bilateral finasteride induced gynecomastia have also been reported in 1mg of oral finasteride(Propecia®). We report two cases of finasteride(Propecia®) induced painful bilateral gynecomastia, which are the first published documentations in Korea. | - |
dc.format.extent | 3 | - |
dc.language | 한국어 | - |
dc.language.iso | KOR | - |
dc.publisher | 대한피부과학회 | - |
dc.title | Two cases of reversible bilateral painful gynecomastia induced by 1mg oral finasteride(Propecia®) | - |
dc.title.alternative | Two Cases of Reversible Bilateral Painful Gynecomastia Induced by 1㎎ Oral Finasteride(Propecia?) | - |
dc.type | Article | - |
dc.identifier.bibliographicCitation | Korean Journal of Dermatology, v.41, no.2, pp 232 - 234 | - |
dc.identifier.kciid | ART000902596 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-0037960305 | - |
dc.citation.endPage | 234 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 232 | - |
dc.citation.title | Korean Journal of Dermatology | - |
dc.citation.volume | 41 | - |
dc.type.docType | Article | - |
dc.publisher.location | 대한민국 | - |
dc.subject.keywordAuthor | Alopecia | - |
dc.subject.keywordAuthor | Finasteride(Propecia®) | - |
dc.subject.keywordAuthor | Gynecomastia | - |
dc.subject.keywordPlus | androstanolone | - |
dc.subject.keywordPlus | androstenedione | - |
dc.subject.keywordPlus | angiotensin receptor antagonist | - |
dc.subject.keywordPlus | atenolol | - |
dc.subject.keywordPlus | finasteride | - |
dc.subject.keywordPlus | losartan potassium | - |
dc.subject.keywordPlus | steroid 5alpha reductase inhibitor | - |
dc.subject.keywordPlus | tamoxifen | - |
dc.subject.keywordPlus | testosterone | - |
dc.subject.keywordPlus | adult | - |
dc.subject.keywordPlus | alopecia | - |
dc.subject.keywordPlus | article | - |
dc.subject.keywordPlus | breast | - |
dc.subject.keywordPlus | case report | - |
dc.subject.keywordPlus | drug approval | - |
dc.subject.keywordPlus | drug induced disease | - |
dc.subject.keywordPlus | food and drug administration | - |
dc.subject.keywordPlus | gynecomastia | - |
dc.subject.keywordPlus | human | - |
dc.subject.keywordPlus | hypertension | - |
dc.subject.keywordPlus | male | - |
dc.subject.keywordPlus | male type alopecia | - |
dc.subject.keywordPlus | treatment outcome | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.